Is there a role for magnetic resonance imaging in a population-based breast cancer screening program?

Breast Journal

Volumn 13, Issue 6, 2007, Pages 543-544

  Sweeney, Karl J ^a   Sacchini, Virgilio ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST SURGERY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CLINICAL DECISION MAKING; COLONOSCOPY; COST EFFECTIVENESS ANALYSIS; EDITORIAL; FAMILY HISTORY; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; UTERINE CERVIX CYTOLOGY;

BREAST NEOPLASMS; EARLY DIAGNOSIS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; PRIMARY PREVENTION; WOMEN'S HEALTH;

EID: 35748969550     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2007.00501.x     Document Type: Editorial

References (14)

1. Saslow D, Boetes C, Burke W, et al. American Cancer Society Guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007 57 : 75 89.
2. Sweeney KJ, Sacchini V. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007 357 : 192.
3. Liberman L. Breast MR imaging in assessing extent of disease. Magn Reson Imaging Clin N Am 2006 14 : 339 49.
4. Rosen PP, Fracchia AA, Urban JA, Schottenfeld D, Robbins GF. "Residual" mammary carcinoma following simulated partial mastectomy. Cancer 1975 35 : 739 47.
5. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002 347 : 1233 41.
6. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003 98 : 468 73.
7. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007 356 : 1295 303.
8. Quality Assurance Guidelines for Breast Cancer Screening Radiology. NHS Cancer Screening Programmes : NHSBSP publication No 59; NHS Cancer Screening Programmes, 2005.
9. Griebsch I, Brown J, Boggis C, et al. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Brit J Cancer 2006 95 : 801 10.
10. Tilanus-Linthorst MMA, Alves C, Seynaeve C, et al. Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer. Brit J Surg 2006 93 : 961 8.
11. Rosen PP, Groshen S, Kinne DW, Norton L. Factors influencing prognosis in node-negative breast carcinoma: analysis of T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol 1993 11 : 2090 100.
12. Swedish Organized Service Screening Evaluation Group. Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer 2007 109 : 2205 12.
13. Lee J, Kaplan JB, Murray MP, et al. DCIS underestimation at MRI-guided 9-guage vacuum-assisted breast biopsy. Am J Roentgenol 2007 189 : 468 74 (in press).
14. Woo PPS, Kim JJ, Leung GM. What is the most cost-effective population-based cancer screening program for Chinese Women?. J Clin Oncol 2007 25 : 617 24.